Taking the North China market as the main focus of health marketing

Wu Xiangjun, general manager of Yiling Pharmaceutical (002603 SZ), said at the Guoxin strategic meeting that the company would not invest too much in the sales cost of large health products, and would focus on the North China market The Chinese patent medicine enterprise Yiling Pharmaceutical Co., Ltd crossed the border last year and has jinliwang health drink, Yimeng health drink and other products Wu said he was optimistic about the prospect of the company's health drink series At present, there are more than 100 million diabetes patients in China, but there is no suitable drink Jinliwang health drink and Yimeng health drink in Yiling have the functions of regulating sleep and assisting in regulating blood sugar, which can just meet the demand of diabetes patients for drinks They are the first in the Chinese market Southwest Securities once published a research report that the success of traditional Chinese medicine health products enterprises mainly depends on the company's popularity and brand, and the promotion of the company's popularity mainly depends on marketing means At present, Yiling pharmaceutical industry has not taken action in the marketing of health drinks, and has not arranged for TV advertisements or print advertisements For the future marketing strategy, Yiling pharmaceutical also holds a very conservative attitude, and has indicated to grand wisdom that it will use some print ads for promotion On January 31 this year, Yiling pharmaceutical announced that it plans to invest in the construction of health drink project, with a total investment of 48 million yuan After reaching the production capacity, 35000 tons of health drink production capacity can be increased After two years, the annual sales revenue will be increased by 299 million yuan and the pre tax profit will be 61.06 million yuan In May this year, Yiling pharmaceutical obtained the qualification of health food production.